Effects of SGLT2 Inhibition on the Mechanisms of Cardiac Damage in the Diabetic Patient With HFpEF
Status:
Recruiting
Trial end date:
2022-12-30
Target enrollment:
Participant gender:
Summary
The main aim of this study is to identify the underlying mechanisms of Sodium-glucose
co-transporter-2 (SGLT2) inhibitors which are associated to better outcomes in patients with
Diabetes mellitus type 2 and Heart Failure with preserved Ejection Fraction.
Phase:
Phase 4
Details
Lead Sponsor:
Hospital General Universitario Gregorio Marañon
Collaborators:
Fundación para la Investigación Biomédica del Hospital Gregorio Maranon Instituto de Salud Carlos III University of Navarra